| Metric | შპს Linema Pharm | სს საქართველოს ნავთობისა და გაზის კორპორაცია |
|---|---|---|
| Growth | ||
| Revenue | ₾3.9m₾1.6m | ₾1.40bn₾1.35bn |
| Revenue growth | 139.8% | 3.8% |
| Profitability | ||
| EBITDA | ₾1.2m₾465k | ₾130.7m₾61.3m |
| EBITDA margin | 31.0%28.7% | 9.3%4.5% |
| Net profit | ₾1.2m-₾90k | ₾50.1m₾109.1m |
| Net margin | 31.0%-5.5% | 3.6%8.1% |
| Balance sheet | ||
| Total assets | ₾7.5m₾6.2m | ₾2.04bn₾2.26bn |
| Total equity | ₾6.4m₾5.4m | ₾1.14bn₾1.08bn |
| ROE | 18.9%-1.6% | 4.4%10.1% |